Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05874479 · ClinicalTrials.gov registry record · NA

Reducing AIR Pollution Exposure to Lower Blood PRESSURE Among New York City Public Housing Residents

A NA study of Blood Pressure, sponsored by NYU Langone Health.

Recruiting
Registry status
NA
Development phase
440
Enrollment target
1
Study location

NCT05874479 is a NA study of Blood Pressure that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 440 participants, above the 283-participant average among 101 other Blood Pressure trials with a reported enrollment target (55% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05874479, a NA study of Blood Pressure, is actively recruiting participants, sponsored by NYU Langone Health.

RECRUITING
Registry status
NA
Development phase
440 participants
Enrollment target
1
Study location

Study Summary

Fine particulate matter \<2.5 µm (PM2.5) air pollution is the fifth leading risk factor for global mortality, with the largest portion of deaths due to cardiovascular disease (CVD). While several mechanisms are responsible, PM2.5-induced elevations in blood pressure (BP) may be relevant. Indoor portable air cleaners (PACs) are a novel approach to reduce exposure to PM2.5 and potentially lower blood pressure. The current study is being conducted to provide evidence that PACs reduce PM2.5 exposure and lower systolic blood pressure (SBP) in key patient populations.

Conditions Studied

Interventions

  • DEVICE Active PAC
  • DEVICE Sham PAC

Study Locations (1)

New York

  • NYU Langone Health - New York

Trial Details

FieldValue
Enrollment Target 440 participants
Start Date 2023-12-20
Est. Completion 2028-03
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT05874479

The ClinicalTrials.gov registry entry for NCT05874479 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 440 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 283-participant average among 101 other Blood Pressure trials with a reported enrollment target (55% higher). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Blood Pressure appearing as the primary indexed condition, and to 2 interventions - of which Active PAC is the first listed.

NCT05874479 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05874479 about?

NCT05874479 is a clinical study titled "Reducing AIR Pollution Exposure to Lower Blood PRESSURE Among New York City Public Housing Residents". Fine particulate matter \<2.5 µm (PM2.5) air pollution is the fifth leading risk factor for global mortality, with the largest portion of deaths due to cardiovascular disease (CVD). While several mechanisms are responsible, PM2.5-induced elevations in blood pressure (BP) may be relevant. Indoor port...

What is the current status of trial NCT05874479?

This trial is currently recruiting. It is a NA study. The enrollment target is 440 participants. The study started on 2023-12-20. Estimated completion is 2028-03.

What conditions does trial NCT05874479 study?

This clinical trial studies the following conditions: Blood Pressure.

What interventions are being tested in trial NCT05874479?

The interventions under investigation include: Active PAC (DEVICE), Sham PAC (DEVICE).

Who is sponsoring clinical trial NCT05874479?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05874479 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Blood Pressure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.